Companies have claimed improvements to yield, batch consistency and output while acknowledging the risks and challenges ...

Earlier this month, the FDA backed off on a pause in shipments of the chikungunya vaccine Ixchiq to older adults. Now, the ...

Arnatar is developing ART4, an antisense oligonucleotide that ups the expression of its target protein to treat a rare ...

The biotech sector has not seen an IPO in six months. The market has remained frozen amid broader macro pressures and the ...

Thousands of employees across the Department of Health and Human Services are set to lose their collective bargaining rights ...

The FDA Adverse Event Reporting System, which Commissioner Marty Makary called “clunky,” previously published updates on a ...